Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation.
Br J Clin Pharmacol
; 83(4): 801-811, 2017 04.
Article
in En
| MEDLINE
| ID: mdl-27792837
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis
/
HIV Infections
/
Isoniazid
/
Antitubercular Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Br J Clin Pharmacol
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom